Black women account for the majority of new HIV infections among women. But despite staggering rates, awareness and treatment efforts still focus on men. The CDC reports that 57% of women who were diagnosed with HIV in 2018 were Black. Grassroots groups are working to change this with the help of a recent $8 million grant from ViiV Healthcare, a pharmaceuticals company that makes an injectable HIV prevention drug, Apretude. The grant is meant to help with community outreach, education and prevention efforts focused on Black women. Black women account for the majority of new HIV infections among women. But despite staggering rates, awareness and treatment efforts still focus on men. Grassroots groups are working to change this with the help of a recent $8 million grant from ViiV Healthcare, a pharmaceuticals company that makes an injectable HIV prevention drug, Apretude. The grant is meant to help with community outreach, education and prevention efforts focused on Black women. Visit the link in bio to learn more.